| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |